TITLE

Flumazenil/propofol interaction

PUB. DATE
October 2008
SOURCE
Reactions Weekly;10/18/2008, Issue 1224, p14
SOURCE TYPE
Periodical
DOC. TYPE
Case Study
ABSTRACT
The article describes the case of an 83-year-old woman who had undergone anaesthesia with propofol, developed post-operative resedation following concomitant administration of flumazenil. After her cardiac surgery, she was monitored and became responsive also after receiving naloxone in preparation for endotracheal tube removal. After further consciousness improvement, she was administered flumazenil 0.2mg to counter any residual midazolam effect.
ACCESSION #
35006033

 

Related Articles

  • Hypoxemia during Moderate Sedation for Gastrointestinal Endoscopy: Causes and Associations. Qadeer, Mohammed A.; Lopez, A. Rocio; Dumot, John A.; Vargo, John J. // Digestion;2011, Vol. 84 Issue 1, p37 

    Background/Aims: Although prolonged hypoxemia (henceforth referred to as hypoxemia) is not uncommon during moderate sedation for endoscopy, there are only sparse data regarding its relationship with medications, endoscopic intubations and ventilation patterns. We aimed to study these...

  • Chronic Nitrofurantoin-Induced Lung Disease. Mendez, Jose L.; Nadrous, Hassan F.; Hartman, Thomas E.; Ryu, Jay H. // Mayo Clinic Proceedings;Oct2005, Vol. 80 Issue 10, p1298 

    OBJECTIVE: To reassess the clinical and radiological features of chronic nitrofurantoin-induced lung disease and eventual clinical outcome. PATIENTS AND METHODS: We retrospectively reviewed the medical records of 18 patients with chronic nitrofurantoin-induced lung disease who were seen at the...

  • Midazolam/nitrous oxide/sufentanil.  // Reactions Weekly;9/19/2009, Issue 1270, p25 

    The article describes the case of a 3-year-old girl who experienced over-sedation and laryngospasm following administration of midazolam, sufentanil and nitrous oxide for sedation. Particular focus is given to the dosing regimen of the patient. She was treated with naloxone and flumazenil, which...

  • Flumazenil.  // Reactions Weekly;6/18/2011, Issue 1356, p18 

    The article describes the case of a 28-year-old woman who developed seizures while receiving treatment with flumazenil.

  • Flumazenil/imatinib/scopolamine butylbromide.  // Reactions Weekly;1/7/2012, Issue 1383, p20 

    The article describes the case of a 75-year-old woman who developed agranulocytosis after receiving flumazenil and scopolamine butylbromide during gastroendoscopy.

  • Flumazenil.  // Reactions Weekly;6/11/2011, Issue 1355, p18 

    The article describes the case of a 68-year-old woman afflicted with Takayasu syndrome who developed difficulty of breathing after the administration of flumazenil after her wisdom tooth extraction.

  • Reversing Agents.  // Cardiovascular Pharmacology Manual;2008, p37 

    The article presents information about several reversing agents, they include naloxone and flumazenil. Some of indications are for the reversal of the overdosage of benzodiazepine and respiratory depression. Their adverse effects include ventricular tachycardia, hypertension and ventricular...

  • A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites. Jatoi, Aminah; Nieva, Jorge J.; Qin, Rui; Loprinzi, Charles L.; Wos, Edward J.; Novotny, Paul J.; Moore Jr., Dennis F.; Mowat, Rex B.; Bechar, Naftali; Pajon Jr., Eduardo R.; Hartmann, Lynn C. // Oncology;Jun2012, Vol. 82 Issue 6, p315 

    Background: Effective, non-invasive, palliative strategies for symptomatic malignant ascites are unavailable. This trial explored whether octreotide, an inhibitor of vascular endothelial growth factor, a putative mediator of ascites, prolongs the interval to next paracentesis. Methods: After a...

  • Methylergometrine.  // Reactions Weekly;11/26/2011, Issue 1379, p26 

    The article describes the case of a female neonate who developed mottled skin with cyanotic extremities and diminished, shallow respiration thirty minutes after inadvertently given intramuscular methylegometrine 0.1 milligram, and was successfully managed with intramuscular naloxone 0.4 milligrams.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics